1-3 of 3
Joel D. Leverson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade

Frederick J. Kohlhapp, Dipica Haribhai, Rebecca Mathew, Ryan Duggan, Paul A. Ellis, Rui Wang, Elisabeth A. Lasater, Yan Shi, Nimita Dave, Jacob J. Riehm, Valerie A. Robinson, An D. Do, Yijin Li, Christine J. Orr, Deepak Sampath, Aparna Raval, Mark Merchant, Anahita Bhathena, Ahmed Hamed Salem, Keith M. Hamel, Joel D. Leverson, Cherrie Donawho, William N. Pappano, Tamar Uziel
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2021) 11 (1): 68–79.
https://doi.org/10.1158/2159-8290.CD-19-0759
Published: 06 January 2021
View articletitled, Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade
Open the PDF for Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax

Joel D. Leverson, Deepak Sampath, Andrew J. Souers, Saul H. Rosenberg, Wayne J. Fairbrother, Martine Amiot, Marina Konopleva, Anthony Letai
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2017) 7 (12): 1376–1393.
https://doi.org/10.1158/2159-8290.CD-17-0797
Published: 04 December 2017
View articletitled, Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax
Open the PDF for Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax in another window
Journal Articles

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan, Leah J. Hogdal, Juliana M. Benito, Donna Bucci, Lina Han, Gautam Borthakur, Jorge Cortes, Daniel J. DeAngelo, LaKeisha Debose, Hong Mu, Hartmut Döhner, Verena I. Gaidzik, Ilene Galinsky, Leonard S. Golfman, Torsten Haferlach, Karine G. Harutyunyan, Jianhua Hu, Joel D. Leverson, Guido Marcucci, Markus Müschen, Rachel Newman, Eugene Park, Peter P. Ruvolo, Vivian Ruvolo, Jeremy Ryan, Sonja Schindela, Patrick Zweidler-McKay, Richard M. Stone, Hagop Kantarjian, Michael Andreeff, Marina Konopleva, Anthony G. Letai
Journal: Cancer Discovery
Cancer Discov (2014) 4 (3): 362–375.
https://doi.org/10.1158/2159-8290.CD-13-0609
Published: 03 March 2014
View articletitled, Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Open the PDF for Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia in another window
Includes: Supplementary data